The importance of CA 72-4 and CA 19-9 dosing in gastric cancer

Serological analysis of tumor markers has emerged as a non-invasive method for monitoring cancer patients, including tumor recurrence and response to treatment. Tumor markers have the potential to aid in both the diagnosis and prognosis of cancer, but their most important role currently lies in the...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicine and life 2023-02, Vol.16 (2), p.186-188
Main Authors: Roșu, Mihai Cătălin, Ardelean, Andrei, Moldovan, Silviu Daniel, Faur, Flaviu Ionut, Nesiu, Alexandru, Totoloci, Bogdan Dan
Format: Article
Language:English
Subjects:
Antigens, Tumor-Associated, Carbohydrate - therapeutic use
Biomarkers
Biomarkers, Tumor
CA-19-9 Antigen - therapeutic use
Cancer therapies
Carcinoembryonic Antigen
Cell division
Gastric cancer
Gastrointestinal surgery
Glycoproteins
Humans
Kinases
Medical prognosis
Medical research
Neoplasm Recurrence, Local
Ovarian cancer
Prognosis
Proteins
Review
Serology
Stem cells
Stomach Neoplasms - drug therapy
Stomach Neoplasms - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Serological analysis of tumor markers has emerged as a non-invasive method for monitoring cancer patients, including tumor recurrence and response to treatment. Tumor markers have the potential to aid in both the diagnosis and prognosis of cancer, but their most important role currently lies in the monitoring of tumor progression. Tumor markers can also provide valuable information on treatment effectiveness, with changes in plasma values indicating tumor regression or progression. This research aimed to investigate the correlation between the serum detection values of three tumor markers - CEA, CA 19-9, and CA 72-4 - and their utility in the diagnosis and prognosis of patients with gastric cancer. The study seeks to uncover the relationship between these tumor markers and the evolution of gastric cancer, providing insights into their potential use in clinical practice.
ISSN:1844-122X
1844-3117
DOI:10.25122/jml-2022-0173